Related Experiment Video
Updated: Dec 2, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Broad genic repression domains signify enhanced silencing of oncogenes
Dongyu Zhao1,2,3,4, Lili Zhang5,6,7, Min Zhang2,3,4
1Center for Bioinformatics and Computational Biology, Houston Methodist Research Institute, Houston, TX, USA.
Abstract:
Cancers result from a set of genetic and epigenetic alterations. Most known oncogenes were identified by gain-of-function mutations in cancer, yet little is known about their epigenetic features. Through integrative analysis of 11,596 epigenomic profiles and mutations from >8200 tumor-normal pairs, we discover broad genic repression domains (BGRD) on chromatin as an epigenetic signature for oncogenes. A BGRD is a widespread enrichment domain of the repressive histone modification H3K27me3 and is further enriched with multiple other repressive marks including H3K9me3, H3K9me2, and H3K27me2. Further, BGRD displays widespread enrichment of repressed cis-regulatory elements. Shortening of BGRDs is linked to derepression of transcription. BGRDs at oncogenes tend to be conserved across normal cell types. Putative tumor-promoting genes and lncRNAs defined using BGRDs are experimentally verified as required for cancer phenotypes. Therefore, BGRDs play key roles in epigenetic regulation of cancer and provide a direction for mutation-independent discovery of oncogenes.
Insights
Researchers discovered broad genic repression domains (BGRDs) as a new epigenetic signature for oncogenes. These domains, marked by repressive histone modifications, help identify cancer-driving genes independently of mutations.
Area of Science:
- Cancer Biology
- Epigenetics
- Genomics
Background:
- Cancers arise from genetic and epigenetic changes.
- Oncogenes are typically identified by gain-of-function mutations.
- Epigenetic features of oncogenes remain largely unexplored.
Purpose of the Study:
- To identify novel epigenetic signatures associated with oncogenes.
- To explore the role of chromatin modifications in cancer development.
- To develop mutation-independent methods for oncogene discovery.
Main Methods:
- Integrative analysis of 11,596 epigenomic profiles and >8200 tumor-normal mutation pairs.
- Characterization of broad genic repression domains (BGRDs) using histone modification data (H3K27me3, H3K9me3, H3K9me2, H3K27me2).
- Analysis of cis-regulatory element enrichment and BGRD length correlation with gene transcription.
Main Results:
- Discovery of broad genic repression domains (BGRDs) as an epigenetic signature for oncogenes.
- BGRDs are characterized by widespread enrichment of repressive histone marks (H3K27me3, H3K9me3, etc.) and repressed cis-regulatory elements.
- Shortening of BGRDs correlates with gene derepression, and BGRDs at oncogenes are conserved in normal cells.
- Putative oncogenes and lncRNAs identified via BGRDs were experimentally validated as crucial for cancer phenotypes.
Conclusions:
- Broad genic repression domains (BGRDs) are key epigenetic regulators in cancer.
- BGRDs offer a novel, mutation-independent strategy for identifying oncogenes.
- This discovery advances our understanding of epigenetic mechanisms in cancer and oncogene identification.
More Related Videos
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Co-activators and Co-repressors